Page last updated: 2024-08-17

nad and alpha-synuclein

nad has been researched along with alpha-synuclein in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (62.50)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Brown, DR; Davies, P; Moualla, D1
Barrientos, A; Liu, J; Ocampo, A1
Bubacco, L; Girotto, S; Gratton, E; Jahid, S; Plotegher, N; Stringari, C; Veronesi, M1
Abramov, AY; Angelova, PR; Buchman, VL; Gandhi, S; Ludtmann, MH; Ninkina, NN1
Kráľová Trančíková, A; Pokusa, M1
Tan, EK; Zhou, ZD1
Gentry, MS; Macedo, JKA; Ostrakhovitch, EA; Quintero, JE; Song, ES; van Horne, C; Yamasaki, TR1
Facey, PD; Hirth, F; Kocinaj, A; Parsons, AE; Parsons, RB; Prendergast, SA; Ruiz Pulido, G1

Reviews

1 review(s) available for nad and alpha-synuclein

ArticleYear
Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson's disease.
    Ageing research reviews, 2020, Volume: 62

    Topics: alpha-Synuclein; Humans; Mitochondria; NAD; Parkinson Disease; Sirtuin 3

2020

Other Studies

7 other study(ies) available for nad and alpha-synuclein

ArticleYear
Alpha-synuclein is a cellular ferrireductase.
    PloS one, 2011, Jan-10, Volume: 6, Issue:1

    Topics: alpha-Synuclein; Cell Line; Copper; FMN Reductase; Humans; Iron; Kinetics; Lewy Body Disease; NAD; Neurons; Parkinson Disease

2011
NAD+ salvage pathway proteins suppress proteotoxicity in yeast models of neurodegeneration by promoting the clearance of misfolded/oligomerized proteins.
    Human molecular genetics, 2013, May-01, Volume: 22, Issue:9

    Topics: alpha-Synuclein; Gene Expression; Histone Deacetylases; Mitochondria; NAD; Niacinamide; Nicotinamide-Nucleotide Adenylyltransferase; Oxidative Phosphorylation; Peptides; Protein Folding; Saccharomyces cerevisiae; Wallerian Degeneration

2013
NADH fluorescence lifetime is an endogenous reporter of α-synuclein aggregation in live cells.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015, Volume: 29, Issue:6

    Topics: alpha-Synuclein; Fluorescence; HEK293 Cells; Humans; Lewy Bodies; Magnetic Resonance Spectroscopy; Microscopy, Confocal; Microscopy, Electron, Transmission; Models, Biological; NAD; Parkinson Disease; Protein Aggregates; Protein Binding; Spectrometry, Fluorescence

2015
Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, 10-12, Volume: 36, Issue:41

    Topics: Adenosine Triphosphate; alpha-Synuclein; Animals; Astrocytes; Brain; Cells, Cultured; Energy Metabolism; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitochondrial Proton-Translocating ATPases; NAD; Oxygen Consumption; Unfolded Protein Response

2016
FLIM analysis of intracellular markers associated with the development of Parkinson's disease in cellular model.
    Physiological research, 2018, 12-31, Volume: 67, Issue:Suppl 4

    Topics: alpha-Synuclein; Biomarkers; Cell Line, Tumor; Humans; Inclusion Bodies; Intracellular Fluid; Membrane Potential, Mitochondrial; Mitochondria; NAD; Optical Imaging; Parkinson Disease

2018
Analysis of circulating metabolites to differentiate Parkinson's disease and essential tremor.
    Neuroscience letters, 2022, 01-19, Volume: 769

    Topics: Aged; alpha-Synuclein; Biomarkers; Diagnosis, Differential; Essential Tremor; Female; Humans; Male; Middle Aged; NAD; Nicotinamide Phosphoribosyltransferase; Parkinson Disease; Pentose Phosphate Pathway

2022
Alpha-synucleinopathy reduces NMNAT3 protein levels and neurite formation that can be rescued by targeting the NAD+ pathway.
    Human molecular genetics, 2022, 08-25, Volume: 31, Issue:17

    Topics: alpha-Synuclein; Dopaminergic Neurons; Humans; NAD; Neurites; Neuroblastoma; Nicotinamide-Nucleotide Adenylyltransferase; Parkinson Disease; Synucleinopathies

2022